Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

KSGal6ST is essential for the 6-sulfation of galactose within keratan sulfate in early postnatal brain.

Tytuł:
KSGal6ST is essential for the 6-sulfation of galactose within keratan sulfate in early postnatal brain.
Autorzy:
Hoshino H; Section of Pathophysiology and Neurobiology, Research, National Center for Geriatrics and Gerontology, (HH, SO, KU), Obu, Japan.
Foyez T
Ohtake-Niimi S
Takeda-Uchimura Y
Michikawa M
Kadomatsu K
Uchimura K
Źródło:
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society [J Histochem Cytochem] 2014 Feb; Vol. 62 (2), pp. 145-56. Date of Electronic Publication: 2013 Oct 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: <2011->: Thousand Oaks, CA : SAGE Publications
Original Publication: Baltimore : Williams & Wilkins Co., c1953-
MeSH Terms:
Brain/*metabolism
Galactose/*metabolism
Keratan Sulfate/*metabolism
Sulfotransferases/*metabolism
Animals ; Animals, Newborn ; Brain/growth & development ; HeLa Cells ; Humans ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; RNA, Messenger/metabolism ; Sulfotransferases/genetics ; Time Factors ; Carbohydrate Sulfotransferases
References:
J Neurochem. 1995 Nov;65(5):2327-37. (PMID: 7595522)
J Neuroimmunol. 1998 May 1;85(1):69-77. (PMID: 9626999)
J Biol Chem. 2013 Sep 13;288(37):26533-45. (PMID: 23880769)
J Biol Chem. 2008 Nov 28;283(48):33026-35. (PMID: 18838383)
J Comp Neurol. 1997 Apr 21;380(4):533-52. (PMID: 9087531)
Glia. 2000 Jun;30(4):401-10. (PMID: 10797620)
Invest Ophthalmol Vis Sci. 1990 Mar 1;31(3):419-28. (PMID: 2138589)
Neuroscience. 2012 Sep 18;220:47-61. (PMID: 22728091)
Glycobiology. 2000 Oct;10(10):951-8. (PMID: 11030741)
J Histochem Cytochem. 1991 Sep;39(9):1175-87. (PMID: 1717545)
Glycobiology. 2000 Feb;10(2):203-11. (PMID: 10642612)
Eur J Biochem. 1986 Jun 2;157(2):385-91. (PMID: 2423332)
Biochem J. 1986 May 15;236(1):71-5. (PMID: 2431678)
J Biol Chem. 2002 Mar 29;277(13):10982-6. (PMID: 11790764)
J Biol Chem. 1997 Dec 19;272(51):32321-8. (PMID: 9405439)
Trends Immunol. 2006 Dec;27(12):559-65. (PMID: 17049924)
J Biol Chem. 2002 Nov 8;277(45):42505-13. (PMID: 12218059)
Am J Pathol. 2012 May;180(5):2056-67. (PMID: 22429964)
Am J Pathol. 2005 Aug;167(2):505-15. (PMID: 16049335)
Glycobiology. 2001 Oct;11(10):779-90. (PMID: 11588154)
Perspect Dev Neurobiol. 1996;3(4):273-90. (PMID: 9117260)
J Neurosci. 2010 Apr 28;30(17):5937-47. (PMID: 20427653)
Glycobiology. 1996 Jan;6(1):51-7. (PMID: 8991509)
J Biol Chem. 2004 Aug 13;279(33):35001-8. (PMID: 15175329)
IUBMB Life. 2002 Oct;54(4):187-94. (PMID: 12512857)
J Neurosci. 2002 Jun 1;22(11):4611-24. (PMID: 12040068)
Glycobiology. 2013 Mar;23(3):381-94. (PMID: 23254996)
J Biol Chem. 1998 Aug 28;273(35):22577-83. (PMID: 9712885)
Nature. 1984 Feb 16-22;307(5952):650-2. (PMID: 6420711)
Science. 1997 Jul 4;277(5322):94-8. (PMID: 9204907)
Annu Rev Immunol. 2004;22:129-56. (PMID: 15032576)
J Biol Chem. 2008 Nov 7;283(45):30879-89. (PMID: 18713734)
Glycobiology. 2006 Aug;16(8):702-10. (PMID: 16624895)
J Biol Chem. 1983 Jul 25;258(14):8848-54. (PMID: 6223038)
J Cell Biol. 1994 Aug;126(3):783-99. (PMID: 7519189)
J Biochem. 1998 Sep;124(3):670-8. (PMID: 9722682)
J Histochem Cytochem. 1993 Apr;41(4):481-7. (PMID: 8450191)
Mol Neurobiol. 2008 Apr-Jun;37(2-3):93-103. (PMID: 18465098)
J Biol Chem. 1986 Jun 25;261(18):8237-42. (PMID: 2941416)
Nature. 2007 Apr 26;446(7139):1030-7. (PMID: 17460664)
Nat Biotechnol. 2002 Oct;20(10):1011-7. (PMID: 12219077)
J Biol Chem. 1987 Aug 25;262(24):11634-40. (PMID: 2957372)
J Biol Chem. 1996 Sep 20;271(38):23535-46. (PMID: 8798563)
Nat Immunol. 2005 Nov;6(11):1096-104. (PMID: 16227985)
J Biol Chem. 2001 May 11;276(19):16271-8. (PMID: 11278593)
Nat Immunol. 2005 Nov;6(11):1105-13. (PMID: 16227986)
J Biol Chem. 1953 Dec;205(2):611-6. (PMID: 13129238)
Nat Neurosci. 2012 Jan 15;15(3):414-22, S1-2. (PMID: 22246436)
Nat Genet. 2000 Oct;26(2):237-41. (PMID: 11017086)
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15829-34. (PMID: 17890318)
J Biol Chem. 1994 Apr 22;269(16):12142-6. (PMID: 7512960)
Am J Pathol. 2003 Jul;163(1):183-96. (PMID: 12819023)
J Biol Chem. 2005 Jun 24;280(25):23615-21. (PMID: 15849197)
J Neurosci. 2011 Nov 23;31(47):17091-102. (PMID: 22114278)
Hybridoma. 1984 Winter;3(4):347-61. (PMID: 6396197)
Glycobiology. 2013 Mar;23(3):322-36. (PMID: 23154990)
Brain Pathol. 2009 Jan;19(1):58-68. (PMID: 18410407)
Eur J Biochem. 1994 Sep 1;224(2):281-308. (PMID: 7925342)
Neuroscience. 1995 Jul;67(1):23-35. (PMID: 7477903)
Biochim Biophys Acta. 2002 Dec 19;1573(3):312-8. (PMID: 12417413)
Eur J Biochem. 1999 Aug;263(3):879-88. (PMID: 10469154)
Glycobiology. 2007 Mar;17(3):277-93. (PMID: 17172261)
Contributed Indexing:
Keywords: 5D4; developing brain; extracellular matrix; glycosaminoglycan; keratan sulfate; phosphacan; sulfotransferase
Substance Nomenclature:
0 (RNA, Messenger)
9056-36-4 (Keratan Sulfate)
EC 2.8.2.- (Sulfotransferases)
X2RN3Q8DNE (Galactose)
Entry Date(s):
Date Created: 20131025 Date Completed: 20140318 Latest Revision: 20231213
Update Code:
20240104
PubMed Central ID:
PMC3902094
DOI:
10.1369/0022155413511619
PMID:
24152993
Czasopismo naukowe
Keratan sulfate (KS) comprises repeating disaccharides of galactose (Gal) and N-acetylglucosamine (GlcNAc). Residues of Gal and GlcNAc in KS are potentially modified with sulfate at their C-6 positions. The 5D4 monoclonal antibody recognizes KS structures containing Gal and GlcNAc, both 6-sulfated, and has been used most extensively to evaluate KS expression in mammalian brains. We previously showed that GlcNAc6ST1 is an enzyme responsible for the synthesis of the 5D4 epitope in developing brain and in the adult brain, where it is induced after injury. It has been unclear which sulfotransferase is responsible for Gal-6-sulfation within the 5D4 KS epitope in developing brains. We produced mice deficient in KSGal6ST, a Gal-6-sulfotransferase. Western blotting and immunoprecipitation revealed that all 5D4-immunoreactivity to proteins, including phosphacan, were abolished in KSGal6ST-deficient postnatal brains. Likewise, the 5D4 epitope, expressed primarily in the cortical marginal zone and subplate and dorsal thalamus, was eliminated in KSGal6ST-deficient mice. Disaccharide analysis showed the loss of Gal-6-sulfate in KS of the KSGal6ST-deficient brains. Transfection studies revealed that GlcNAc6ST1 and KSGal6ST cooperated in the expression of the 5D4 KS epitope in HeLa cells. These results indicate that KSGal6ST is essential for C-6 sulfation of Gal within KS in early postnatal brains.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies